After losing his battle with neuroblastoma aged 6, Felix left an incredible legacy which will help countless children just like him. Read more
The summer months are always busy here for team SKC with lots of exciting things around the corner in Autumn to prepare for. Read more
Find out more about the latest breakthrough from researchers across Europe on the significance of ALK gene alterations in high-risk neuroblastoma. Read more
In 2018, we announced our awarded membership to the Association of Medical Research Charities (AMRC), but what does this actually mean for our research? Read more
The Spring months have been as busy as ever for our research team, with the announcement of our latest project as well as progress reviews for our ongoing work and looking ahead at the SKC research strategy for the coming years. Read more
A closer look into the National Cancer Registration and Analysis Service (NCRAS) 2021 report on cancer in children, teenagers and young adults. Read more
Last month, researchers from the Wellcome Sanger Institute, Great Ormond Street Hospital and Princess Máxima Centre published a new single cell study that has shown all neuroblastomas arise from one type of developmental cell called sympathoblasts. We had the opportunity to speak with one of the lead authors of this work, Dr. Jan Molenaar of the Princess Máxima Centre about its significance and what it means for patients. Read more
We have started the year with a new addition to the research team, our Research and Digital Comms Officer Emily Hall who will be focused on sharing and celebrating our research work and helping families navigate the world of neuroblastoma research. Read more
In honour of the International Day for Women and Girls in Science, we've been chatting to our Senior Trials Coordinator Dr Emma pond about her role and the fantastic work she does for SKC. Read more
Every 2 years the Advances in Neuroblastoma Research conference invites researchers and clinicians worldwide who work in the field of neuroblastoma to come together and share their latest work. Read more
We are delighted to have announced the first International Neuroblastoma Research Initiative award to be funded under our AMRC-accredited research funding process, which will see a targeted drug introduced to frontline treatment for children with the hope of dramatically increasing survival rates. Read more
This Autumn we are extremely busy with our ongoing International Neuroblastoma Research Initiatives. Read more